High-dose statin for every stroke: The good, the bad, and the unknown

Stroke

Volumn 43, Issue 7, 2012, Pages 1996-1997

  Selim, Magdy H ^a   Molina, Carlos A ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

neuroprotectants; statins

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; CHOLESTEROL; CREATINE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; LIVER ENZYME; MEVINOLIN; SIMVASTATIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR;

BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CREATINE KINASE BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG WITHDRAWAL; HUMAN; MYOPATHY; NEUROPROTECTION; NONHUMAN; NOTE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK REDUCTION; SIDE EFFECT; STROKE; STROKE PATIENT; TREATMENT OUTCOME;

BRAIN ISCHEMIA; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; STROKE;

EID: 84863299859     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.648832     Document Type: Note

References (3)

1. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, et al. Treating to New Targets (TNT) Investigators. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005; 352:1425-1435. (Pubitemid 40471450)
2. Montaner J, Chacón P, Krupinski J, Rubio F, Millán M, Molina CA, et al. Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial. Eur J Neurol. 2008;15:82-90. (Pubitemid 350265291)
3. Elkind MS, Sacco RL, Macarthur RB, Peerschke E, Neils G, Andrews H, et al. High-dose lovastatin for acute ischemic stroke: results of the phase-I dose escalation neuroprotection with statin therapy for acute recovery trial (NeuSTART). Cerebrovasc Dis. 2009;28:266-275.